Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 4

2(28.6%)

7Total

N/A(5)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06907472Not ApplicableActive Not Recruiting

Diabetes Management for Primary Healthcare Centers.

Role: lead

NCT07351162Not ApplicableNot Yet Recruiting

Hypertension Treatment in Nigeria 2.0

Role: collaborator

NCT06927674Not ApplicableRecruiting

DELIVER Evaluation in Nigeria

Role: collaborator

NCT06927661Not ApplicableRecruiting

ENSAND 2.0 Evaluation in Nigeria

Role: collaborator

NCT05953753Not ApplicableTerminated

Enhancing Access to Safe and Nutritious Diets (ENSAND) Evaluation Nigeria

Role: collaborator

NCT06400784Phase 4Completed

Hypertensive Heart Failure Treatment in SSA

Role: lead

NCT02742467Phase 4Completed

Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans

Role: lead

NCT03598673Completed

To Determine the Effect of Nebivolol on Office Blood Pressure of Blacks Residing in Nigeria

Role: lead

All 8 trials loaded